
US and Indian Pharmacopeias Collaborate on Drug Quality
The two pharmacopeias signed a Memorandum of Understanding as recognition of their collaboration for developing international science-based standards.
The US Pharmacopeial Convention (USP)
USP and IPC have collaborated on projects in the past, and USP CEO Dr. Ronald T. Piervincenzi stated, in a press release, that he felt the MOU would be “a significant step forward in how two standard setting bodies can work together to improve global health through quality standards … Our collaboration will amplify the global public health impact of both organizations by leveraging our mutual scientific resources to advance international standards.”
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.